After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel

cafead

Administrator
Staff member
  • cafead   Feb 22, 2024 at 12:02: PM
via As Roche officially abandoned cancer drug Gavreto, its former partner Blueprint Medicines has found the RET inhibitor a new owner in the U.S.

article source